Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Monetizing a YouTube channel can be lucrative. Learn various ways to turn your content into a source of income.
9,382 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Is a $5 trillion Apple valuation possible by the end of 2026? This guide weighs the growth engines, risks, and action...
Adobe has pulled back about 40% from its peak, but new AI-driven products and expanding ARR are reinvigorating the bu...
NVIDIA reported explosive quarterly results powered by AI-driven demand, pushing margins higher and signaling sustain...
Coinbase’s plan to launch a $22 billion prediction market faces a public tests after an AI-generated alert wrongly cl...
Grab's CEO recently sold 400,000 Class A shares for about $1.6 million. This insider move raises the question: should...
A veteran security professional's life offers lessons beyond protection. Explore how celebrity bodyguard mason haynes...
Marvell Technology tumbles on revised AI capex forecasts, intensifying a wider retreat in semiconductor names. Major ...
As AI partnerships captivate the market, UiPath shares edged higher amid broader tech weakness. This look at stock ma...
MicroStrategy unveils a refreshed liquidity framework, lifting cash reserves but leaving questions about its long-ter...
Netflix has struggled lately, slipping sharply even after a solid earnings report. This article breaks down what the ...
After a long hiatus from the tech scene, Peter Steinberger—a millennial coder turned OpenClaw founder—re-emerged to w...